Gemina Announces Closing of $910,000 Convertible Note Financing

3 weeks ago

VANCOUVER, BC / ACCESSWIRE / March 19, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to…

Catheter Precision, Inc. (NYSE American:VTAK) to Sponsor the Monaco USA Arrhythmia Course

3 weeks ago

FORT MILL, SC / ACCESSWIRE / March 19, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based…

Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy (CIPN) at the AACR 2024 Annual Meeting

3 weeks ago

PRINCETON, NJ / ACCESSWIRE / March 19, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical…

SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET

3 weeks ago

-  Update on the Phase 3 REGAL Clinical Trial of GPS in Acute Myeloid Leukemia (AML) - -  Update on…

U.S. Oral Surgery Management Enters Maryland, Adds Five New Partner Practices in Five States

3 weeks ago

USOSM President and CEO Richard Hall USOSM President and CEO Richard Hall says exceptional patient care and overall clinical excellence…

Autonomix Appoints Jennifer Cook as Chief Business Officer

3 weeks ago

Autonomix Medical, Inc. Mrs. Jennifer Cook Proven executive with 28 years of success building winning B2C & B2B businesses, brands,…

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

3 weeks ago

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage…

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes

3 weeks ago

NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development…

Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University

3 weeks ago

DURHAM, N.C., March 19, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing…

Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates

3 weeks ago

Financing includes participation from new and existing investors Net proceeds, along with existing cash, cash equivalents and marketable securities, are…